Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT01658787

Global Registry for Endovascular Aortic Treatment (GREAT)

Prospective, observational Registry to obtain data on device performance and clinical outcomes.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Multiple Pathologies

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

Loading trial locations.

About this study

This is a prospective observational cohort Registry designed to obtain data on device performance and clinical outcomes of patients treated with Gore Endovascular Aortic products.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minimum age required by state regulations
  • Indication for aortic endovascular stent graft repair
  • Signed informed consent

Exclusion criteria

  • N/A

Treatment and study plan

Endovascular aortic repair

Device

Treatment with Gore Endovascular Aortic Products.

Primary outcomes

  1. To collect "real world" data on the incidence of serious device events.

    Time frame: Up to 10 years

Sponsors and collaborators

Lead sponsor

W.L.Gore & Associates

Industry

Registry information

Official study title

'GREAT' Global Registry for Endovascular Aortic Treatment - Outcomes Evaluation

Acronym: GREAT

Important dates

Study start
2010
Primary completion
2027
Study completion
2027
First posted
Aug 7, 2012
Registry last updated
Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.